Cannabis Law Report

APRIL 14, 2022

Cannabis businesses that are ill-prepared for these regulatory requirements risk facing litigation, enforcement actions, fines or penalties, and negative publicity, while those taking a proactive approach to compliance may find opportunities to mitigate and even monetize those risks. Next Steps.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

APRIL 5, 2022

April 05, 2022 (GLOBE NEWSWIRE) — Metrc, the most trusted and experienced provider of cannabis regulatory systems in the U.S., Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. Their third new state contract in as many weeks.

Safety 52

Safety Patients Dispensary Compliance 52

Cannabis Law Report

JULY 13, 2022

The 2022-23 budget and accompanying tax reform bill will provide significant and immediate relief to cannabis businesses, support equity operators, strengthen enforcement tools against illegal cannabis operators, and protect youth, environmental, and public safety programs funding.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues. 74 solvents. 21 microbes.

Research and Development 92

Research and Development Agriculture Data Extraction 92

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

JULY 1, 2022

The position will be developing and evaluating OPS’s Training program, Licensing and Compliance (TLC) system as well as OPS’s product tracking system. Close date: 7/20/2022. Evaluate licensing and compliance program systems, policies, and operations. See the job announcement below. www.oregon.gov/psilocybin. REQ-100990.

Programs 52

Programs Compliance Compliance Research and Development 52

Cannabis Law Report

MAY 29, 2022

To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision. 12] DEA, Drug Scheduling, [link] (last visited May 13, 2022). [13] 1, 2022), [link]. [14]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

AUGUST 3, 2021

HempFusion’s substantial investment into regulatory compliance will help solidify Apothecanna’s leadership position in the CBD industry. Product efficiencies across topicals line while providing a near term opportunity for expansion into ingestible products supported by HempFusion’s proprietary formulations.

Research and Development 105

Research and Development Topical Events Compliance 105

Cannabis Law Report

AUGUST 5, 2019

The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018. Any tweaking of laws will only happen post-2022 when the report has been fully digested by the relevant parties.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

AUGUST 25, 2021

Sagely Naturals”), (together the “Acquisitions”) for fiscal 2021 and 2022. million in fiscal 2021 and USD$20 million to $25 million in fiscal 2022 due in large part to the Company’s expansion plans over the next 18 months and beyond. million in revenue. million and $13.5 pull week ending 5/22/21)].

Retail 111

Retail Supply Chain Research and Development Events 111

Cannabis Law Report

JANUARY 20, 2022

First, a manufacturer can make an independent GRAS conclusion by determining a substance is generally recognized, “among experts qualified by scientific training and experience to evaluate its safety.” Licensees have until July 1, 2022, to sell off their current inventory of product containing artificially derived cannabinoids.

Cannabinoids 52

Cannabinoids THC Food Hemp 52

Cannabis Law Report

DECEMBER 16, 2021

Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. Nevada Cannabis Compliance Board Takes Action for Tax Payment Failures.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Net revenue. Adjusted EBITDA 3.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. At the time of FY 2020 results publication, we estimated that EUR 250m revenues had been lost in FY 2020 due to the impact of COVID-19 lockdowns and travel restrictions and the objective was to recover these revenues by 2022.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

FEBRUARY 19, 2021

We’re going to skip the data highlights today and dive right into our very special interview. In between seed-to-sale tracking, we collect upwards of 370 different unique events in the supply chain, that then the state agency has complete visibility into so that they can monitor for compliance. Amanda Guerrero: Hey, Ed.

Seed-To-Sale 52

Seed-To-Sale Environment Supply Chain Data 52

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

AUGUST 16, 2021

The Company anticipates this particular account to generate north of $500,000 for 2021 and approximately $1 million or more in 2022. The initial order for approximately $250,000 was shipped in July 2021. HempFusion’s ecommerce business is growing. New customer acquisition increased online by 69.7%

eCommerce 105

eCommerce Retail Research and Development CBD 105

SpeedWeed

JULY 21, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 52

Dispensary Packaging Terpenes Consumption 52

SpeedWeed

JULY 21, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Cultivation 52

Cultivation Legislation Dispensary Packaging 52

Cannabis Law Report

MARCH 9, 2019

London law firm Mackrell Turner Garrett, together with a leading food and trading standards barrister, were instructed by the Cannabis Trades Association UK (CTA) to make representations to the European Food Safety Authority (EFSA). US analysts say CBD could be a $22bn market by 2022; by comparison, any EU sector would larger.

CBD 87

CBD Food Seed-To-Sale Extraction 87

SpeedWeed

JULY 22, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 52

Dispensary Packaging Terpenes Consumption 52

SpeedWeed

JULY 28, 2021

From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation.

Dispensary 52

Dispensary Packaging Terpenes Consumption 52

Cannabis Law Report

MAY 26, 2022

was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. Available online 18 May 2022. The lowest rate (44%) was in a community where law enforcement had recently enforced underage alcohol laws using compliance checks (i.e., The success rate ranged from 44% to 97%.

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Cannabis Law Report

NOVEMBER 5, 2021

– Integrated solution provides a single platform for compliance with vaccination status tracking and weekly testing requirements – STONY BROOK, N.Y. & By providing both vaccine status management and weekly COVID-19 testing, the integrated platform offers a single solution for compliance with the ETS.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Igniting the Public Market and Cross-Border Optimism.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Cannabis Law Report

FEBRUARY 17, 2022

The impact you’ll make: Provide advice and counsel to the engineering, product and design team regarding new and existing product offerings and functionalities in light of rapidly changing applicable laws, including those related to data privacy and security, and company policies and strategy.

Research and Development 59

Research and Development Compliance Compliance Policy 59

WeedAdvisor

JUNE 27, 2019

government data.”. This is at odds with the federal government’s tendency to adapt more slowly – at least when it comes to tracking labour data. With the 2018 Farm Bill removing hemp from the list of Schedule I controlled substances, it is likely that the hemp industry could see itself featured in the 2022 statistics.

Marijuana 53

Marijuana Compliance Compliance Data 53

Cannabis Law Report

MAY 14, 2022

Based upon the significant public concern for safety and lack of scientific and public health data related to the conversion process, the state’s Cannabis Regulatory Agency withdrew the proposed rulemaking. The program was officially adopted during the 2022 legislative session.

Banking 52

Banking Recreational Research and Development Cannabis 52